YOU ARE HERE > Home > News

News

The French Generics Market

“The French Generics Market 2017-2022 prospects” report provides a documented, detailed and robust analysis of the French generics and biosimilars markets and evaluates the determinants of their likely evolution by 2022.

Read more
Build Best-in-Class Hospital KAMs

We are pleased to offer you this new position paper that presents concepts, methods and tools to build Best-in-Class Hospital KAMs.

Read more
The French Pharma Market

“The French Pharma Market 2016-2022 prospects” report provides a description of the French healthcare system from a legal, organizational and economic point of view. The report also includes a detailed analysis of French pharmaceutical market sales by segment, company and product and an assessment of the impact of its evolution on the pharmaceutical market and pharmaceutical companies by 2022.

Read more
Time Management

14-page and easy-to-read document, including a method, tools and 8 practical tips that could save you ~3 hours per day and, thus, increase your efficiency and improve your quality of life

Read more
Training Pharma Strategy & Marketing 2017

Smart Pharma Consulting offers a high-level training for pharmaceutical professionals wishing to strengthen their skills in the following areas:

- Strategic marketing

- Tactical marketing

- Management 

in both domestic and international environments

Read more
7 tips to become a Smart Manager

7 practical tips to help pharma companies to transform their "Good Managers" into "Smart Managers" 

Read more
Recruitment of a senior consultant

Smart Pharma Consulting recruits a senior consultant

Read more
Recruitment of a business analyst

Smart Pharma Consulting recruits a business analyst

 

Read more
Boost the impact of your Medical Reps with the ELITE Program

We are pleased to offer you this new position paper that presents concepts, methods and tools to build Best-in-Class Medical Reps.

Read more
Boost your Brands with the Brand Booster Program

We are pleased to offer you this new position paper that presents concepts, methods and tools to build Best-in-Class Pharma Marketers.

Read more
Boost your MSLs Competence and Performance

We are pleased to offer you this new position paper that presents methods and tools as well as advice to build Best-in-Class MSL teams.

Read more
The Best of Smart Pharma 2016

We are pleased to offer you this 205-page book which covers pharma companies key issues related to:

- Strategy

- Medical Affairs

- Marketing & Sales

- Management

Read more
Global Pharmaceutical Market - Outlook 2016-2026

The new report, in French, “Marché pharmaceutique mondial – Perspectives 2016-2026”, provides insight into the global pharmaceutical market by 2026 and an analysis of the strategic implications for pharmaceutical companies.

Read more
Professional Training - February 2017

The next session of our training program will be held in Paris from 6th to 10th 2017.

Read more
Brand Preference Optimization

We present, in this new position paper:
- The concept of brand preference
- The approach of "Brand Preference Mix" and its application to all pharmaceutical  stakeholders
- Practical tools to measure the preference level of stakehodlers and to evaluate the "preferential" power of services
- Practical examples of initiatives likely to strengthen the preference to brands.

Read more
What patient services pharma companies should propose?

In this new position paper, we respond precisely to the following key questions: What does "patient centricity" mean for pharmaceutical companies in practice? Why is a strategy focused on patients necessary? How to develop such a strategy? How to implement it?

Read more
Pharma Strategy & Marketing Training in October

The next session of the high-level training "Pharma Strategy & Marketing" will be held in Paris from October 17th to 21st 2016.

Read more
How to create a superior Pharma Corporate Reputation?

This new position paper offers an analysis of the importance of corporate reputation, a review of recent studies on the reputation of pharmaceutical companies and a presentation of the "Pharma Corporate Reputation BoosterTM", an approach that we have developed to help pharmaceutical companies enhance their own reputation.

Read more
Does Smart Pharma deliver Smarter Services?

The purpose of this document is to demonstrate to Pharma Companies that Smart Pharma Consulting is aptly named and delivers Smarter Services

Read more
Drug Value & Market Access Optimization

June 2016 - The "Drug Value & Market Access Optimization" report has been designed as a working tool to help pharmaceutical companies optimize the valuation of their drugs

Read more
Is Smart Pharma Consulting Innovative?

The objective of this position paper is to share with Pharma Companies some of the most innovative ideas developed by Smart Pharma Consulting since it was funded, 15 years ago

Read more
How can Creativity boost your Performance?

The objective of this position paper is to help Pharma Companies boost the Creativity of their collaborators and of their organization

Read more
How to optimize Mature Brand Performance?

The objective of this position paper is to help Pharma Companies optimize the performance of their Mature Brands

Read more
The Supplementary Health Insurance in France

The objective of the position paper is to give a clear picture of the Supplementary Health Insurance in France and to identify the opportunities for collaboration for Pharma Companies

Read more
Smart Pharma Consulting speaks at PharmagoraPlus

Jean-Michel Peny discussed his vision of the future of pharmacies in France by 2020.

Read more
Le marché des génériques en France - Perspectives 2015 - 2020

Le marché des génériques en France - Perspectives 2015 - 2020” report provides facts and figures about the specificities of the French generics market (retail and hospital) and its evolution, as well as the evolution of the essentially similars and biosimilars markets, the key regulatory measures and their related impacts, the competitive environment, the levers to improve the performance of pharma companies, to help stakeholders better understand the key success factors of this market and to understand its outlook for 2020.

Read more
The Customer Brand Preference Plan

The objective of the “Customer Brand Preference Plan” is to help pharmaceutical companies improve the robutness and consistency of their brand plans.

Read more
Medical Science Liaisons

The objective of the “Medical Science Liaisons” position paper is to help pharmaceutical companies maximize the performance of their MSLs.

Read more
KOL Partnership Model

The objective of the “KOL Partnership Model” is to help pharmaceutical companies maximize the relevance and value of their partnerships.

Read more
2020 Pharma Trends & Marketing Challenges

This position paper has selected 12 market trends and 7 marketing challenges likely to impact pharma companies by the end of 2020, leading to 5 recommendations.

Read more